新型3-取代(硫)色满-4-酮衍生物的合成及其结构表征

以取代或未取代(硫)色满酮和芳香醛为原料,在氢氧化钠催化下,分别采用常规溶剂法与无溶剂研磨法两种不同方式,合成一系列新型的3-取代(硫)色满-4-酮衍生物3a～3l.无溶剂研磨法具有操作简便、反应条件温和、反应时间短、对环境友好等优点.所合成的标题化合物的结构通过IR,1H NMR,13C NMR和MS进行了鉴定和表征.     

2,3-二苯基-4-噻唑酮类衍生物的合成及抑菌活性研究

本文以取代苯甲醛、苯胺及巯基乙酸为原料,合成了一系列2,3-二苯基-4-噻唑酮类衍生物,其结构经~1H NMR和MS确证。抑菌活性试验显示,所有目标化合物表现出中等抑菌活性,其中化合物4g对苹果腐烂病菌的抑菌活性最高,能达到62.7%。构效关系研究表明在2,3-二苯基-4-噻唑酮的苯基上引入甲基能增强活性。     

具有生物活性的4-色满酮衍生物的合成进展

4-色满酮衍生物在自然界中广泛存在,大多数都具有生物活性。具有生物活性的4-色满酮衍生物又大多具有手性,尤其C2位置。有关它们的不对称合成引起了有机合成工作者的广泛关注。C2(手性)-4-色满酮衍生物合成的关键是C2手性中心的控制合成。本文根据4-色满酮衍生物构建方式的不同进行分类,概述了近十几年来合成C2(消旋或手性)4-色满酮衍生物的最新方法, 侧重讨论了合成立体结构专一的C2(手性)-4-色满酮的反应特点。     

新型含1,3,4-噻二唑的硫色满酮衍生物的合成及其抗真菌活性

以取代苯硫酚和顺丁烯二酸酐为原料,经迈克尔加成反应制得2-羧基-硫色满酮衍生物（2a~2d）; 2a~2d分别与氨基硫脲反应制得2-(5-氨基-1,3,4-噻二唑-2-基)硫色满-4-酮衍生物（3a~3d）; 3a~3d与酰氯经酰化反应合成了14个新型的含1,3,4-噻二唑的硫色满酮衍生物（5a~5n）,其结构经^1H NMR, ¹³C NMR和HR-ESI-MS表征。采用微量稀释法测定了5a~5n的抗真菌活性。结果表明：部分化合物对絮状表皮癣菌和总状毛霉菌有较好的抑制活性,优于阳性对照药氟康唑。     

3-苯基-噻吩并嘧啶-4-酮衍生物的合成及其抑菌活性

利用三组分氮杂Wittig反应,以三氢环戊二烯并噻吩基磷亚胺、异氰酸苯酯和酚,合成了13种未见文献报道的2-芳氧基-3-苯基-3,5,6,7-四氢-4H-环戊二烯并[4,5]噻吩并[2,3-d]-嘧啶-4-酮衍生物,产率63%～78%。 通过IR、1H NMR、MS和元素分析测试技术对目标化合物的结构进行了表征。 抑菌试验显示,所合成的化合物对真菌(桔青霉菌）的抑制活性优于对细菌的抑制活性。     

新型黄烷酮的合成及其抑菌活性

以异香草醛和2,4,6-三羟基苯乙酮为起始原料,经过C-异戊烯基化、选择性地甲基化或甲氧甲基化、羟醛缩合、催化环化与加成共6步反应,首次合成了两个新型黄烷酮—5,7,4'-三甲氧基-3'-羟基-8-(3”-羟基-3”-甲基-丁基)黄烷酮(1a)和5,7,4'-三甲氧基-3'-羟基-8-(3”,甲氧基-3”-甲基-丁基)...     

3-[(5-取代硫基)-4H-1,2,4-三唑-3-基]苯并吡喃-2-酮的合成与抑菌活性

为寻找具有杀菌活性的三唑类先导化合物,采用活性亚结构拼接方法,将香豆素环和硫醚结构单元引入到三唑类化合物分子中,合成一系列未见文献报道的新型含香豆素环和硫醚结构的三唑类衍生物。经~1H NMR、~(13)C NMR、IR、MS和元素分析对所合成化合物的结构进行了表征。初步生物活性测试表明,部分目标化合物在试验浓度下具有一定的抑菌活性。     

新型1,5-二苯基-1,4-戊二烯-3-酮肟酯类化合物的合成及其抑菌活性研究

以1,5-二苯基-1,4-戊二烯-3-酮肟和酰氯为原料, 合成了15个新型的1,5-二苯基-1,4-戊二烯-3-酮肟酯类化合物, 通过元素分析, IR, ¹H NMR, ¹³C NMR等对其结构进行了表征. 初步生物活性试验结果表明, 在50 mg•L^－1浓度下, 化合物3i和3o对小麦赤霉病菌抑制率分别为51.1%和 53.4%, 与对照药剂恶霉灵抑制活性相当.     

无溶剂研磨法合成1,4-二氢吡啶衍生物

以醛、乙酰乙酸乙酯及碳酸氢铵为原料,研磨一步合成1,4-二氢吡啶衍生物,该方法具有快速、简便、环境友好等特点.     

2-[(吡啶-3-基)甲氨基]-1H-咪唑-4(5H)-酮衍生物的合成及其抑菌活性

本文以2-硫代乙内酰脲、取代苯甲醛、碘甲烷、吡啶甲胺等为原料,经Knoevenagel缩合、甲基化和取代反应,合成了一系列5-取代苯亚甲基-2-[(吡啶-3-基)甲氨基]-1H-咪唑-4(5H)-酮(3a~3i),其结构经IR、~1H NMR、~13C NMR和HRMS确证。初步抑菌活性试验表明,在药剂浓度为100μg/m L时,目标化合物对灰霉菌均有中等抑制活性,抑制率为69.5%~83.2%;在相同浓度下大部分化合物对菌核菌有较高的抑制活性,抑制率为87.9%~100%,其活性高于对照药三唑酮和百菌清。     

Synthesis and Antibacterial Activity of Some New 4(3H)Quinazolin-4-one Derivatives

2-Phenylamino-6,8-dibromo-4H-3,1-benzoxazinone has been reacted with nitrogen nucleophiles, such as hydrazine hydrate, amines, and formamide, yielding 4(3H)quinazolinone derivatives; and with sulfur nucleophiles producing the corresponding thioesters. The behavior of aminoquinazolinone and 4(3H)quinazolinone towards some carbon electrophiles under different conditions has been studied.     

新型4,4-二甲基异噁唑-3-酮衍生物的合成及生物活性研究

以Baylis-Hillman加成物为起始原料,设计并合成了5个结构新颖的4,4-二甲基异唑-3-酮衍生物。所合成的化合物经IR、1HNMR和元素分析确证。生物活性测试结果表明,所合成的目标产物在2000gai/ha的剂量下均具有较好的除草活性。中间体1-(2,4-二氯苯基)-2-溴甲基丙烯酸乙酯具有杀虫活性,在600gai/ha的剂量下对朱砂叶螨防效为100%。     

含香豆素骨架的缩氨基硫脲化合物的合成和抑菌活性研究

由含不同取代基的水杨醛与乙酰乙酸乙酯在六氢吡啶存在下,得到一系列乙酰基香豆素中间体,然后进一步与氨基硫脲发生缩合反应,得到含有香豆素骨架的缩氨基硫脲化合物,目标化合物的结构均由IR、1H NMR 13C NMR和HRMS确证.它们对大肠杆菌和枯草杆菌具有优良的抑制效果,其中以二氯代的标题化合物的效果最佳.     

1-取代哌啶-4-酮肟醚的合成与杀菌活性测定

以取代苄胺或苯乙胺为起始原料, 依次经Michael 加成, Dieckmann缩合, 水解脱羧, 肟化和醚化等多步反应合成了11个未见文献报道的1-取代哌啶-4-酮肟醚5a～5k. 目标化合物的结构经元素分析, IR, 1H NMR和MS测定确证. 初步杀菌活性测试表明, 部分化合物有较好的杀菌活性.     

Synthesis and Antibacterial Activities of Erythromycin Derivatives

Ten new erythromycin antibacterial agents containing amidino group were designed and synthesized from erythromycin via oximation, reduction and condensation. Their structures were confirmed by MS and ^13C NMR; the synthetic condition(reaction medium)was explored; and their in vtiro antibacterial activities were tested. Compound HMA-3 showed antibacterial activity against staphylococcus aureus, which is equivalent to that of erythromycin A. Compounds HMA-8 and HMA-4 also showed an antibacterial activitiy. But no compound showed bactericidal activity.     

Synthesis of 3-Substituted Pyrazole Derivatives by Mixed Anhydride Method and Study of Their Antibacterial Activities

A convenient synthesis of 3-substituted pyrazole derivatives by a mixed anhydride method using i-butylchloroformate and N-methylmorpholine at ?20 °C in tetrahydrofuran and study of in vitro antibacterial activities of the prepared compounds against Staphylococcus epidermidis, Bacillus subtilis, Pseudomonas aeruginosa, and Proteus valguris by agar-diffusion method were carried out. The results suggested that the products 4a, 4b, and 4c exhibited moderate to feeble inhibition against all test bacteria at greater concentration but 4d was best against Staphylococcus epidermidis (22 mm) and worst against Pseudomonas aeruginosa (16 mm) at the greatest concentration (2.5 mg/ml), and the activities decreased with decrease in concentration.

[Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications® for the following free supplemental resource(s): Full experimental and spectral details.]     

1,3-取代吲哚-2-酮衍生物的合成与肿瘤细胞毒活性研究

以苯胺为原料,通过肟化、环合生成二氢吲哚-2,3-二酮,再对其进行N-烷基化、亲核加成和磺酰化反应得到目标化合物5a～5g和7a～7e。通过¹H NMR、¹³C NMR确认其结构。采用噻唑蓝（MTT）法测试了目标化合物对乳腺癌细胞MDA-MB-231、鼠黑色素瘤细胞B16、鼠结肠癌细胞CT26三种肿瘤细胞的体外抑制活性。结果表明,化合物7d、7e具有明显的肿瘤细胞毒活性,其中化合物7d对MDA-MB-231的细胞毒活性比阳性药五氟尿嘧啶更强,IC₅₀为4.63±0.14μmol/L。本文结果可为进一步研究具有肿瘤细胞毒活性的吲哚酮类衍生物提供参考。     

Synthesis and Antibacterial Activity of Novel Oxazolidinone Analogs Containing Substituted Thiazole/Fused-Bicyclic Groups

IntroductionOxazolidinones, exemplified by linezolid, are anovel class of totally synthetic antibacterial agents withactivities against a variety of clinically important sus-ceptible and resistant Gram-positive pathogenic bacteriasuch as methicillin-resis…     

Synthesis and antimicrobial activities of novel quinazolin-4(3H)-one derivatives containing a 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole moiety

A series of novel quinazolin-4(3H)-one derivatives (6a–6y) containing a 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole moiety were designed and synthesized, and their structures were fully characterized by ¹H NMR, ¹³C NMR, HRMS and IR spectra. Among them, the structure of compound 6u was unambiguously confirmed via single crystal X-ray diffraction analysis. The obtained bioassay results showed that compounds 6h, 6k, 6l and 6y had the EC₅₀ (half-maximal effective concentration) values of 34.8, 28.2, 41.5 and 42.5 μg/mL against the phytopathogenic bacterium Xanthomonas oryzae pv. oryzae (Xoo), respectively, which were significantly better than commercial bactericide Bismerthiazol (EC₅₀ = 95.8 μg/mL). Additionally, compounds 6a and 6b exhibited the strong inhibition activity against the pathogen Xanthomonas axonopodis pv. citri (Xac).     

Synthesis and Antibacterial Activity of Oxazolidinone Derivatives Containing Nitro Heteroaromatic Moiety

A series of novel oxazolidinone derivatives containing nitro heteroaromatic moiety was synthesized and characterized by means of ¹H NMR and MS spectra. All target compounds were evaluated for their in vitro antibacterial activities against S.au 29213, methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant Enterococcus(VRE) by minimum inhibitory concentration(MIC) assay. Most of them exhibited antibacterial activity against S. au 29213, MRSA and VRE. Among them, compounds 10e and 10f displayed better activity than the control.